Cerus Corporation CERS
$2.46
▼ -1.16% 24H
About
Cerus Corporation is a biomedical products company dedicated to enhancing blood transfusion safety through its INTERCEPT Blood System. This platform inactivates a broad range of pathogens, including viruses, bacteria, and parasites, in blood components to reduce the risk of transfusion-transmitted infections. The INTER…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees261
TickerCERS
Statistics
Market Cap$492.8M
Revenue (TTM)$233.8M
Net Income-$15.6M
Net Margin-6.7%
EPS$-0.08
P/E-32.94
P/S2.40
P/B7.69
EV/EBITDA-328.35
ROE-15.4%
Dividend Yield—
Price$2.46
Data: Twelve Data · Revenue = mcap / P/S